The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA

Journal of Virology

Volumn 74, Issue 23, 2000, Pages 11108-11114

  Greengard, O ^a   Poltoratskaia, N ^a   Leikina, E ^a   Zimmerberg, J ^a   Moscona, A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; HN PROTEIN; SIALIC ACID; SIALIDASE; ZANAMIVIR;

ARTICLE; CELL FUSION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HELA CELL; HEMADSORPTION; HUMAN; HUMAN CELL; INFLUENZA VIRUS; NONHUMAN; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; RECEPTOR BINDING; SYNCYTIUM;

ANTIVIRAL AGENTS; CELL FUSION; ENZYME INHIBITORS; GUANIDINES; HELA CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; NEURAMINIDASE; ORTHOMYXOVIRIDAE; PARAINFLUENZA VIRUS 3, HUMAN; PYRANS; SIALIC ACIDS; ZANAMIVIR;

EID: 0034469926     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.23.11108-11114.2000     Document Type: Article

References (34)

1. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events
2. The pathway of membrane fusion catalyzed by influenza hemagglutinin: Restriction of lipids, hemifusion, and lipidic fusion pore formation
3. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers
4. An efficient method for introducing macromolecules into living cells
5. Proton nuclear magnetic resonance studies of the binding of sialosides to intact influenza virus
6. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections
7. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells in infectivity
8. Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position
9. The hemagglutinin-neuraminidase of human parainfluenza virus type 3: Role of the neuraminidase in the viral life cycle
10. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion
11. Paramyxovirus fusion: A hypothesis for changes
12. Orthomyxoviridae: The viruses and their replication
13. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3
14. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors
15. Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme
16. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid
17. Influenza virus hemagglutinin-induced cell-planar bilayer fusion: Quantitative dissection of fusion pore kinetics into stages
18. Comparison of transient and successful fusion pores connecting influenza hemagglutinin expressing cells to planar membranes
19. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
20. Fusion properties of cells persistently infected with human parainfluenza virus type 3: Participation of hemagglutinin-neuraminidase in membrane fusion
21. Fusion properties of cells infected with human parainfluenza virus type 3: Receptor requirements for viral spread and virus-mediated membrane fusion
22. Relative affinity of the human parainfluenza virus 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity
23. Fusogenic mechanisms of enveloped virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reported gene activation
24. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of action
25. Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA)
26. The initial fusion pore induced by baculovirus GP64 is large and forms quickly
27. Fluorimetric assay of neuraminidase with a sodium 4-methylumbelliferyl-α-D-N-acetylneuraminidase substrate
28. Initial stages of influenza hemagglutinin-induced cell fusion monitored simultaneously by two fluorescent events: Cytoplasmic continuity and lipid mixing
29. Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: Analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography
30. Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid
31. Rational design of potent sialidase-based inhibitors of influenza virus replication
32. Synthesis of 2′-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid and detection of skin fibroblast neuraminidase in normal humans and in sialidosis
33. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro
34. Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion